JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
TRIP.COM-S
09961
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | ---- | -37.44%118.05B | ---- | ---- | ---- | -17.16%188.71B | ---- | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | ---- | -60.71%-13.81B | ---- | ---- | ---- | -29.20%-8.59B | ---- | ---- |
Interest expense - adjustment | ---- | ---- | ---- | 19.03%11.89B | ---- | ---- | ---- | 26.11%9.99B | ---- | ---- |
Dividend (income)- adjustment | ---- | ---- | ---- | 42.41%-546M | ---- | ---- | ---- | -43.64%-948M | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | -135.96%-5.8B | ---- | ---- | ---- | -1.92%16.13B | ---- | ---- |
Impairment and provisions: | ---- | ---- | ---- | -86.15%6.23B | ---- | ---- | ---- | 79.73%44.97B | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | -86.15%6.23B | ---- | ---- | ---- | 79.73%44.97B | ---- | ---- |
Revaluation surplus: | ---- | ---- | ---- | -72.66%2.12B | ---- | ---- | ---- | 116.24%7.75B | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | -72.66%2.12B | ---- | ---- | ---- | 116.24%7.75B | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | 97.45%-4.41B | ---- | ---- | ---- | -46.35%-172.82B | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | -16.67%-126M | ---- | ---- | ---- | ---108M | ---- | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | 97.52%-4.28B | ---- | ---- | ---- | -46.26%-172.71B | ---- | ---- |
Depreciation and amortization: | ---- | ---- | ---- | -3.61%59.01B | ---- | ---- | ---- | 6.15%61.22B | ---- | ---- |
-Depreciation | ---- | ---- | ---- | -7.52%26.31B | ---- | ---- | ---- | 8.71%28.44B | ---- | ---- |
-Amortization of intangible assets | ---- | ---- | ---- | -0.21%32.7B | ---- | ---- | ---- | 4.02%32.77B | ---- | ---- |
Exchange Loss (gain) | ---- | ---- | ---- | 160.51%383M | ---- | ---- | ---- | 21.27%-633M | ---- | ---- |
Special items | ---- | ---- | ---- | 38.49%64.35B | ---- | ---- | ---- | 10.96%46.47B | ---- | ---- |
Operating profit before the change of operating capital | ---- | ---- | ---- | 23.53%237.46B | ---- | ---- | ---- | -5.22%192.23B | ---- | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | 256.70%1.88B | ---- | ---- | ---- | -192.60%-1.2B | ---- | ---- |
Accounts receivable (increase)decrease | ---- | ---- | ---- | -123.29%-1.01B | ---- | ---- | ---- | 207.70%4.34B | ---- | ---- |
Accounts payable increase (decrease) | ---- | ---- | ---- | 182.62%9.39B | ---- | ---- | ---- | -158.56%-11.37B | ---- | ---- |
prepayments (increase)decrease | ---- | ---- | ---- | 193.65%5.47B | ---- | ---- | ---- | 67.16%-5.84B | ---- | ---- |
Special items for working capital changes | ---- | ---- | ---- | 157.57%3.82B | ---- | ---- | ---- | -389.45%-6.64B | ---- | ---- |
Cash from business operations | ---- | 27.59%156.76B | ---- | 47.73%256.69B | ---- | 41.39%122.87B | ---- | -14.70%173.76B | ---- | -12.88%86.9B |
Other taxs | ---- | -52.41%-30.31B | ---- | -37.83%-35.05B | ---- | -14.43%-19.88B | ---- | 11.80%-25.43B | ---- | -3.46%-17.38B |
Special items of business | 21.71%204.48B | ---- | 16.14%72.35B | 114.38%322M | 52.06%168.01B | ---- | 84.19%62.3B | -834.10%-2.24B | -10.85%110.49B | ---- |
Net cash from operations | 21.71%204.48B | 22.80%126.46B | 16.14%72.35B | 51.93%221.96B | 52.06%168.01B | 48.13%102.98B | 84.19%62.3B | -16.61%146.09B | -10.85%110.49B | -16.19%69.52B |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | 133.76%8.86B | ---- | 21.67%10.35B | ---- | 35.01%3.79B | ---- | 72.78%8.51B | ---- | 0.97%2.81B |
Dividend received - investment | ---- | 156.74%2.29B | ---- | -8.26%2.01B | ---- | -27.29%890M | ---- | -34.06%2.19B | ---- | -11.62%1.22B |
Loan receivable (increase) decrease | ---- | -123.91%-126M | ---- | 126.76%655M | ---- | 429.38%527M | ---- | 75.82%-2.45B | ---- | 96.72%-160M |
Decrease in deposits (increase) | ---- | 45.63%-35.74B | ---- | -131.60%-80.71B | ---- | -471.66%-65.72B | ---- | -5,981.50%-34.85B | ---- | -154.25%-11.5B |
Sale of fixed assets | ---- | -39.02%100M | ---- | -31.65%257M | ---- | 1.23%164M | ---- | 96.86%376M | ---- | 128.17%162M |
Purchase of fixed assets | ---- | -97.51%-12.55B | ---- | 7.37%-21.01B | ---- | 50.21%-6.36B | ---- | 22.60%-22.68B | ---- | 19.27%-12.76B |
Purchase of intangible assets | ---- | -54.72%-18.46B | ---- | 6.29%-26.4B | ---- | 24.10%-11.93B | ---- | 14.28%-28.17B | ---- | -9.90%-15.72B |
Sale of subsidiaries | ---- | ---- | ---- | -57.58%14M | ---- | 100.00%14M | ---- | --33M | ---- | --7M |
Recovery of cash from investments | ---- | 10.46%36.16B | ---- | 21.17%61.42B | ---- | -5.49%32.73B | ---- | -25.54%50.69B | ---- | 61.78%34.63B |
Cash on investment | ---- | 33.11%-25.98B | ---- | 8.62%-71.75B | ---- | 16.36%-38.83B | ---- | 56.90%-78.52B | ---- | 47.29%-46.42B |
Other items in the investment business | 32.36%-79.24B | ---- | -4.18%-67.92B | ---- | -35.39%-117.16B | ---- | -224.29%-65.2B | ---- | 39.93%-86.53B | ---- |
Net cash from investment operations | 32.36%-79.24B | 46.36%-45.45B | -4.18%-67.92B | -19.35%-125.16B | -35.39%-117.16B | -77.50%-84.72B | -224.29%-65.2B | 41.26%-104.87B | 39.93%-86.53B | 53.18%-47.73B |
Net cash before financing | 146.27%125.23B | 343.67%81.01B | 252.52%4.43B | 134.84%96.8B | 112.28%50.85B | -16.21%18.26B | -121.16%-2.9B | 1,325.69%41.22B | 219.08%23.96B | 214.80%21.79B |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -7.48%47.88B | ---- | 109.85%63.45B | ---- | 115.43%51.75B | ---- | -46.44%30.24B | ---- | 47.74%24.02B |
Refund | ---- | -24.23%-40.75B | ---- | -84.67%-44.01B | ---- | -649.22%-32.8B | ---- | -0.46%-23.83B | ---- | 65.42%-4.38B |
Issuing shares | ---- | 37.35%1.23B | ---- | 26.22%1.27B | ---- | 296.90%897M | ---- | -43.33%1B | ---- | -64.52%226M |
Interest paid - financing | ---- | -9.04%-6.07B | ---- | -22.86%-11.48B | ---- | -30.93%-5.57B | ---- | -24.15%-9.34B | ---- | -19.77%-4.25B |
Dividends paid - financing | ---- | -43.05%-30.41B | ---- | -44.13%-21.79B | ---- | -58.85%-21.26B | ---- | -8.71%-15.12B | ---- | -3.40%-13.38B |
Issuance expenses and redemption of securities expenses | ---- | -145.43%-61.93B | ---- | -83.94%-53.91B | ---- | -352.43%-25.23B | ---- | -1,250.55%-29.31B | ---- | ---5.58B |
Other items of the financing business | -140.95%-151.33B | -148.69%-6.95B | -4,420.61%-15.51B | -23.99%-9.46B | -59.89%-62.81B | 6.33%-2.8B | -95.27%359M | 35.99%-7.63B | -198.88%-39.28B | 6.57%-2.98B |
Net cash from financing operations | -140.95%-151.33B | -165.40%-99.78B | -4,420.61%-15.51B | -37.73%-82.57B | -59.89%-62.81B | -308.08%-37.6B | -95.27%359M | -377.30%-59.95B | -198.88%-39.28B | -196.13%-9.21B |
Effect of rate | -144.56%-754M | -101.65%-37M | 75.58%-212M | -81.97%1.35B | -77.55%1.69B | -45.42%2.25B | -91.19%-868M | 342.99%7.51B | 591.65%7.54B | 344.97%4.11B |
Net Cash | -118.30%-26.1B | 2.92%-18.77B | -335.90%-11.09B | 175.95%14.23B | 22.00%-11.96B | -253.72%-19.34B | -111.93%-2.54B | -202.61%-18.73B | -178.16%-15.33B | 233.85%12.58B |
Begining period cash | 9.94%172.32B | 9.94%172.32B | 9.94%172.32B | -6.68%156.74B | -6.68%156.74B | -6.68%156.74B | -6.68%156.74B | 9.93%167.97B | 9.93%167.97B | 9.93%167.97B |
Cash at the end | -0.69%145.47B | 9.93%153.51B | 5.02%161.02B | 9.94%172.32B | -8.55%146.48B | -24.38%139.65B | -18.80%153.33B | -6.68%156.74B | -6.26%160.18B | 30.30%184.66B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.